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Abstract
Background: Angiogenesis, the growth of capillaries from preexisting blood vessels, has been
extensively studied experimentally over the past thirty years. Molecular insights from these studies have
lead to therapies for cancer, macular degeneration and ischemia. In parallel, mathematical models of
angiogenesis have helped characterize a broader view of capillary network formation and have suggested
new directions for experimental pursuit. We developed a computational model that bridges the gap
betweenthesetwoperspectives,andaddressesaremainingquestioninangiogenicsprouting:howdothe
processes of endothelial cell elongation, migration and proliferation contribute to vessel formation?
Results: We present a multiscale systems model that closely simulates the mechanisms underlying
sprouting at the onset of angiogenesis. Designed by agent-based programming, the model uses
logical rules to guide the behavior of individual endothelial cells and segments of cells. The
activation, proliferation, and movement of these cells lead to capillary growth in three dimensions.
By this means, a novel capillary network emerges out of combinatorially complex interactions of
single cells. Rules and parameter ranges are based on literature data on endothelial cell behavior in
vitro. The model is designed generally, and will subsequently be applied to represent species-
specific, tissue-specific in vitro and in vivo conditions.
Initial results predict tip cell activation, stalk cell development and sprout formation as a function of
local vascular endothelial growth factor concentrations and the Delta-like 4 Notch ligand, as it
might occur in a three-dimensional in vitro setting. Results demonstrate the differential effects of
ligand concentrations, cell movement and prolifera t i o no ns p r o u t i n ga n dd i r e c t i o n a lp e r s i s t e n c e .
Conclusion: Thissystemsbiology modeloffersaparadigm closely relatedto biologicalphenomena
and highlights previously unexplored interactions of cell elongation, migration and proliferation as a
function of ligand concentration, giving insight into key cellular mechanisms driving angiogenesis.
Background
A san e wc a p i l l a r yg r o w sf r o mab l o o dv e s s e l ,as e r i e so f
cellular processes occur. These vascularization events
have been extensively studied experimentally, however
the whole angiogenic sequence has yet to be character-
ized by any experiment or model, and numerous
unknowns remain. What is known is that an endothelial
cell from an existing vessel becomes activated. The
activated cell starts to migrate into the extracellular
matrix by degrading it; this unique, spindle-shaped cell
is called the tip cell. Cells adjacent to the tip cell begin to
p r o l i f e r a t e ,a n df o l l o wt h et i pc e l l ;t h e ya r er e f e r r e dt oa s
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Open Accessstalk cells. These processes result in formation of a sprout
[1]. This capillary sprout moves towards a stimulus, in
response to chemical cues, mechanical factors, and a
degree of random motility. Finally, the sprout joins an
adjacent capillary. Together these events define the
process of sprouting angiogenesis.
Hypoxia is a main stimulus for angiogenesis during
ischemia, exercise, inflammation, and cancer. In
response to hypoxia, a transcription factor hypoxia-
inducible factor 1 (HIF1) activates hundreds of genes in
cells exposed to low oxygen [2, 3]. These genes include
vascular endothelial growth factor, VEGF. Overall, VEGF
protein stimulates chemotaxis and proliferation of
endothelial cells. There are seven known isoforms of
VEGF, each with a different effect on cell behavior, and
ultimately, on vascular pattern formation [4, 5]; addi-
tionally, there are splice variants of the VEGF isoforms,
VEGFxxxb [6]. Here, we first refer to HIF1-dependent
expression of VEGF and represent the effect of the VEGF-
A( V E G F 165) isoform on cells, unless otherwise specified.
Along with VEGF, another ligand, Delta, and its receptor
play a key role in angiogenic tip cell formation and
proliferation, and the integrity of a microvascular
network. Recent studies have focused on the multiple
effects of Notch-Delta signaling on vascular sprout
formation. Delta-like ligand 4 (Dll4) is a transmembrane
ligand for Notch receptors, and it is critical to vascular
development. So important is Dll4, that like VEGF,
haploinsufficiency of the Dll4 gene is embryonically
lethal in many mouse strains, as a result of extensive
vascular defects [7-9]. Dll4 is primarily expressed in
endothelial cells, and correlated to the local concentra-
tion of VEGF [10], as well as VEGF receptor concentra-
tions. A blockade of VEGF leads to a decrease of Dll4
[11], while Notch-Delta signaling downregulates
VEGFR2 [12]. One study showed the presence of Dll4
reduced tip cell formation as a function of VEGF [13],
and another demonstrated Notch suppressed branching
and proliferation at the sprout tip [7]. A Dll4 deficiency
causes an increase in sprout formation but vessels appear
nonproductive, with less capability of carrying blood or
reducing hypoxia in surrounding tissue [11]. Over-
expression of Dll4 diminishes the growth of new sprout
tips. In the computational research presented here, we
focus on the effects of VEGF protein concentrations and
Dll4 haploinsufficiency on endothelial cells and how
this cell level behavior contributes to differences in
capillary network formation.
Mathematical representations of angiogenesis date to the
1 9 7 0 ' s ,a n dt h e i rn u m b e r sc o n t i n u et oe x p a n dr a p i d l y .
Some of the first models were differential equations
representing a generic growth factor as a chemotactic
stimulus, produced and released by a tumor mass, and
inducing growth of vessels into the tumor [14-16].
Models have since included detailed equation-based
network models of tumor-induced angiogenesis [17], a
model of capillary growth through a corneal pocket assay
[18], molecular level interactions of VEGF complexes
coupled to vessel oxygenation [19], a cell-level rule-
based model of network growth in mesenteric tissue
[20], Potts models of angiogenic growth [21, 22], a
model of tip cell selection as a function of notch-
signaling [23], network formation stemming from
capillary movement through a matrix composed of
aligned collagen fibers [24], and VEGF-driven angiogenic
growth applied to a vascular engineering construct
environment [25], among many others [26-30]. Each
model brings a new perspective on the biological
phenomenon behind neovascularization, and together
they give insight on multiple conditions affecting
angiogenesis, and multiple conditions affected by
angiogenesis. The goal of the current modeling effort is
to provide a framework where many of these models
could be employed or integrated, or at the very least their
hypotheses tested in a new context, specifically related to
biological observations and experimental data.
For this reason, we chose to design the model using the
broad framework of three-dimensional agent-based
modeling. Agent-based programming has roots in social
science, game theory, economics, evolution and public
health. More recently it has emerged as a tool useful for a
range of biomedical applications, including angiogenesis
[ 2 0 ] ,m e m b r a n et r a n s p o r t[ 3 1 ,3 2 ] ,i n f l a m m a t o r y
response [33-35], and tumor growth [36, 37].
Agents are objects that can interact with their environ-
ment, and modify their surroundings. They are analo-
gous to digital organisms familiar to evolutionary
biology in that they carry a computational genome, or
a sequence of instructions (henceforth called rules).
These rules determine the agents' response to logical
functions. The rules of agents require listing the factors
that influence cell behavior as events, with direct
counterparts in biology. Unlike digital organisms, agents
used in the model are not inherently self-replicating.
Agents' rules may evolve, and they may copy their
instructions when modified to represent growth.
In agent-based modeling, global functions (e.g., global
ischemia) and sophisticated rules can govern agent
behavior. Agent interactions with one another and
their environment can also be asynchronous. The rule-
based modeling we describe is a continual, iterative
process, much like perfecting in vitro or in vivo
experiments. As more knowledge is gained, the current
assumptions may change, and a cycle of improvements is
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Furthermore, we start with a very general model – its
parameters will be changed to represent specific species,
tissues and conditions.
We employed this agent-based approach to develop a
three-dimensional, computational model that simulates
cellular sprouting at the onset of angiogenesis. We use
the model to determine and weigh the critical events in
angiogenesis; and differentiate under what microenvir-
onments, which factors dominate and result in a
particular vessel and capillary network phenotype.
The model is based on experimental work found from
extensive literature research, and methods in the model are
closely governed by biological mechanisms. Currently, the
model is applied to conditions that might occur in a three-
dimensional in vitro setting. We represent physiological
changes at the cell level; visually simulate in three
dimensions assumptions behind cell activation, migration,
elongation, proliferation and branching; and test cell level
behavior in response to different stimuli, focusing in the
current model on activation by a threshold change in VEGF
and changes in ligand presence. A novel capillary network
emerges out of this complex interaction of single cells.
Results of the model show the relationship between
growth factor gradients, cell sprouting, cell migration
and cell proliferation. Results also showed how varia-
tions in the mechanisms of cellular persistence alter
vessel growth. We predicted the effects of migration
separate from proliferation on tip cell and stalk cell
movement, and on total vessel growth. Furthermore, the
model represents novel findings of how Delta ligand
changes influence capillary phenotype. Overall, the
model represents a three-dimensional framework upon
which to test and develop biologically realistic mechan-
isms underlying blood vessel growth.
Methods
Model Formulation
Model inputs are coordinates of an initial 3D vascular
network, local VEGF concentrations, binary values for five
parameters (proliferation of tip cells, proliferation of stalk
cells, tip migration, elongation, Dll4 presence), and initial
values of variables. Output is the resulting change in cell
activation, cell position, cell growth and vessel phenotype
after the series of biologically-based rules determine cells'
response to the local environment. Rules are implemented
through logical statements and equations. Rules and
parameter ranges are initially based on available literature
data on endothelial cell behavior in vitro (Tables 1, 2, 3).
While this version focuses solely on endothelial cells,
subsequent iterations of the model can include other cell
types important to different angiogenic processes, e.g.,
smoothmusclecells,pericytes,precursorcellsandastrocytes.
Below we introduce the model, describe individual rules
for cell activity, and explain how the rules work in a
discrete grid. A list of model abbreviations and para-
meters can be found in Tables 1 and 2, respectively,
while initial values for variables are shown in Table S1
(see Additional file 1) and rules are listed in Table 3.
Geometry
At the beginning of each run of the model, the simulation
environment is populated by an initial preexisting
capillary network. In this rendition, the dimensions of
the capillary network are similar to those simulated from
rat extensor digitorum longus (rat skeletal muscle), as in
reference[38].Forthepurposeofshowingtheinitialsteps
in sprouting, several capillaries (two to four capillaries)
were selected randomly from this network. These capil-
laries are represented in the model as connected
Table 1: Model parameters and their abbreviations
Variable Abbreviation
Concentration of A (ng/ml) [A]
Hypoxia inducible factor (HIF1a)H a
Vascular endothelial growth factor VEGF
Matrix metalloproteinase MMP
Notch ligand Delta-like 4 Dll4
Gradient (concentration of species A) (ng/ml/μm) ∇A
Standard deviation s
Probability distribution j
Cell position X(i,j,k)
Velocity (μm/s) ν(i,j,k)
Directional vector d
Persistence p
Degree of randomness μ
Length (μm) ℓ
Time (hr) t
Elongation constant ε
Total tip cell movement mtotal
Migration of the tip cell (μm) Mtip
Elongation of the tip cell (μm) Etip
Elongation of the adjacent stalk cell segment (μm) Estalk
Proliferation of tip cell (% volume increase) Ptip
Proliferation of stalk cell (% volume increase) Pstalk
Cell volume (μm
3)V
Total stalk cell volume in a sprout (μm
3)V sproutStalk
Radius of cell (μm) R
Radius after proliferation (μm) RP
Outer radius of existing capillary (μm) Rcap
Radius of inner lumen in existing capillary (μm) rlumen
Length of tip cell (μm) ℓtip
Length of adjacent stalk cell segment (μm) ℓStalk
Length due to stalk cell growth (μm) APstalk
Length due to tip cell growth (μm) APtip
Length due to stalk cell stretching (μm) AEstalk
Random number generator rgen
Grid height (μm) gH
Grid width (μm) gW
Grid length (μm) gl
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defined in a Cartesian grid, however the methods are
portable to other geometries. There are no inherent size
restrictions on the space modeled. In this model version,
the specific grid dimensions for the program showingtwo
initial capillaries is 20 μmb y2 0μmb y4 0 0μm (160,000
cube-shapedvoxelsof1 μm
3),andthegridsizeshownfor
three capillaries expands to 100 μmb y1 0 0μmb y4 0 0
μm .T h ek - a x i si ss c a l e dd o w nb y1 / 1 0
th, as a visual aid.
Voxels in the model are occupied by part of the
vasculature, or by the matrix and interstitial fluid
surrounding the vasculature. Each voxel is associated
with a computational datastructure that is capable of
storing and passing information in vectors. In the current
model, the voxel-associated datastructure contains infor-
mation on local concentrations of growth factors.
Representation of Cells
Each preexisting capillary vessel is composed of four
endothelial cells. Endothelial cells are represented as a
seriesofsegmentsthatoccupyacylindricalvolumespecified
by a radius and length (Figure 1, gray inset). Segments are
defined by two connected nodes (Figure 1). Each node is
associated with a voxel, and serves as a position used to
calculate the local environment of a cell segment. An
activated tip cell is defined throughout the simulation by
one segment (two nodes) that can vary in length, as the cell
changes position, grows or elongates. Stalk cells are
represented by one activated segment adjacent to the tip
cellandbyanynumberofnonadjacent,quiescentsegments.
As the adjacent stalk cells change position and shape, their
segments can change in number and radius, and the
activated segment closest to the tip cell can change inlength
and radius. Endothelial cells on the preexisting capillaries
have a static length and radius, throughout a model run.
Local VEGF Levels
VEGF gradient, ∇[VEGF], and local VEGF concentrations,
[VEGF], are inputs into the current model and remain
constant for every run of the simulation. This condition
can be relaxed by coupling the cell model to previously
developed VEGF models [39, 40]. For graphs and model
Table 2: Parameters for the cell model
Parameter Value Reference
Default [VEGF]0 0.20 ng/ml, uniform in grid space unless a VEGF
gradient is specified
-
Vessel size Diameter = 3–14 μm [84, 85]
Initial vessel length 400 μm( 1 3 –2000 μm references) [1, 42, 86-89]
Initial cell size in vessel Diameter: 4 μm( 3 –14 μm) [90, 91]
Length: 100 μm( 2 0 –107 μm)
Initial tip cell length 5 μm-
Initial radius of tip cell 1 μm-
Initial length of stalk cells 0 μm-
Initial radius of formed stalk cells 2 μm-
Average distance between initial capillaries 20 μm( 2 0 –40 μm) In skeletal muscle: [92]
In brain tissue: [93]
Initial ratio of stalk cell radius to stalk cell length 0.05–0.1 -
Number of initial endothelial cells per capillary 4 cells (2–6) cells [85, 86, 90]
Number of activated cells adjacent to tip cell 1–2c e l l s -
Initial branch length 0–4.2 μm( m i n i m u mn o n - z e r ob r a n c hl e n g t ho f
1.4 μm growth in one time-step of 2 hrs)
[69, 85, 88, 89]
Branch angle 0–120° [94]
Maximum elongation of stalk cells εmax = 0.5; maximum elongation length is 1.5 ℓstalk
(physiologically, different stimuli cause an increase
of 0.2–1.8× average length)
Addition of EGF; cyclic mechanical
stretch [53, 95]
Maximum elongation of tip cells εmax = 0.5; maximum elongation length is 1.5 ℓtip [53]
Maximum velocity for a cell in three-dimensions 7.5 μm/hr
Radius of lumen (rlumen)C o n s t a n t ; r a n g e 1 –4 μm-
Volume of stalks cells
VR
m =⋅ ⋅ p
m ()
2
3
Astalk
-
Volume of tip cells
VR
m =⋅ ⋅ p
m ()
2
3
A tip
-
Volume of stalk cells in capillary
VR r cap
2
lumen
m =⋅ − ⋅ p
m ()
2
3
Astalk
-
Cell length change as a function of volume change,
where radius to length ratio is held constant
ℓ
3 ≈ volume -
Values are experimentally determined or estimated. The default value used in the model is given first; value ranges found in references and used for
sensitivity analysis are provided in parentheses.
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(page number not for citation purposes)Table 3: Rules and related experimental references for endothelial cell sprouting
Rule Logical or Mathematical Statement Reference
Tip Cell Activation [VEGF] > 0.5 ng/ml, and vacancy in environment surrounding the tip cell [44]
VEGF gradient, global ∇VEGF Variable. -
Default gradient: [VEGF] (ng/ml) in each voxel is uniform, except within a
restricted volume. Within this volume, it is randomly generated at the
start of each model, and dependent on location.The probability
distribution for [VEGF] at location X(i,j,k) is defined by:
f
ps s
([ ] ) exp
[] [], VEGF j
VEGF j VEGF mean j =− ⎛
⎝
⎜
⎞
⎠
⎟
⎡
⎣
⎢
⎢
⎤
⎦
⎥
⎥
⎧
⎨
− 1
2 2
2 ⎪ ⎪
⎩ ⎪
￿ where gw/W2 < i < gw/W1 [] VEGF j C meanj
C
gh
=⋅ − 1 2
￿ where j > gh/H1
￿ where gl·L2 < k < gl·L1
￿ s =C 3 · [ V E G F ] mean,j
Unrestricted Tip Cell Migration Rate
with VEGF, Mtip
T1·[VEGF (in ng/ml)] + migNoVEGF μm/hr [54, 56, 57, 96]
Cell Migration Rate without VEGF,
migNoVEGF
Default: 6.2 μm/hr [62, 97]
Physiological Range: 5–11 μm/hr
1
Tip Cell Migration Rate as a Function
of Extracellular Matrix Composition
and VEGF, Mtip
T2·[VEGF (in ng/ml)] + T3·K (fraction collagen content) +
migNoVEGFMatrix μm/hr
[46, 57, 59, 62, 98]
Cell Migration Rate without VEGF
and minimal/no Matrix,
migNoVEGFMatrix
Default: 1.2 μm/hr [52]
Physiological Range: 1.2–30 μm/hr (collagen IV, 2D to glass, 2D)
Stalk Cell Proliferation with VEGF,
Pstalk
% Cell Proliferation vs. Control = P1·[VEGF (in ng/ml)]+ proNoVEGF
after 48 to 72 hours (approximate average = 60 hrs)
[10, 44, 57-59, 99, 100]
Initial Tip Cell Growth If tip cell is < tipMin in length and no stalk cells are present, tip cell grows
to tipMin in current timestep. Thereafter it follows default rules for
migration, elongation and proliferation.
-
Tip Cell Proliferation and Dll4
+/-
Effect on Tip Proliferation, Ptip
For Dll4 +/+, tip cell proliferates at a rate of Pstalk with 3% probability [10, 13, 69, 88]
For Dll4 +/-, tip cell proliferates at a rate of Pstalk with 8% probability
Tip Cell Division If tip cell is > tipMax in length, tip cell divides into two cells. The leading
cell remains a tip cell, while the cell adjacent to the stalk cells takes on the
stalk cell phenotype and rules.
-
Dll4
+/- Effect on Tip Cell Formation For Dll4
+/-, maximum number of tip cells formed per existing capillary of
400 μml e n g t hi s2 .
[13]
For Dll4
+/+, maximum number of tip cells formed per existing capillary of
400 μml e n g t hi s1 .
Dll4
+/- Effect on Branching For Dll4
+/-, branchCells = 0.4 and branchTipCells = 0.4. [VEGF]
threshold for new tip cell does not need to be crossed. VEGF_branch = 0
ng/ml.
[13]
For Dll4
+/+, branchCells = 0.2 and branchTipCells = 0. VEGF_branch =
0.5 ng/ml.
Persistence as a Function of [VEGF] Weight for a cell's local search is biased in the direction of the global
[VEGF] gradient.
[96] The effects of EGF
(epithelial growth factor) on
persistence was studied in
this reference.
￿ When local [VEGF] gradients are equal in all directions, the weighing
range explored: dirBias/denomBias·[VEGF], where dirBias = 0 to 10 in
one direction, where there are eight restricted directions. See Figure 6.
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uniform [VEGF] throughout the gridspace), or the
∇[VEGF] is defined as in Appendix 1, where noted.
Rules
Behavioral rules based on biophysical properties and
experimental observations govern the activation and move-
mentofendothelialcellsinthemodel.Table3liststhemain
rulesgoverningendothelialcellmigrationandproliferation,
and the related experimental references. To represent
biological mechanisms in the model and perform these
rules, the computer code implements over 80 logical
statements at each timestep, for each active cell segment.
At the beginning of each run of the simulation, Boolean
rules are defined. These rules determine proliferation,
Figure 1
Schematic of the three-dimensional model. Capillaries are represented by endothelial cells. An example of a growing
network with four capillaries is shown in the gray inset. Cells are divided into segments. Each segment is represented by two
nodes. Currently, cell segments are modeled as cylinders specified by a length and radius (gray inset); an activated segment's
length and radius can change during a model run. The local environment surrounding a cell is defined in each voxel of the grid. In
thepresentmodel,voxelscontainvaluesforthelocalVEGFconcentration.Allcellsegmentshavethecapabilityofsensingwhatis
located in the 26 voxels surrounding each of its nodes. For every timestep of the current model, this sensing is restricted to the
leadingnodeofthetipcell(red)andtheadjacentnode(purple),sharedbythetipandactivatedstalksegment.Thelocalsearchfor
the highest growth factor gradient surrounding the leading node of a tip cell determines the direction the sprout tip moves.
BMC Systems Biology 2009, 3:13 http://www.biomedcentral.com/1752-0509/3/13
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ProliferationStalkOn, MigrationTipOn, ElongationOn,
Dll4). At the start of any sequence of rules for tip or stalk
cellsegmentmovement,the valuesof these global Booleans
dictatewhetherornotacertaineventispermitted.Torestrict
elongationfromoccurringduringproliferationofstalkcells,
and vice versa, there are also local Booleans employed for
the individual stalk cells to indicate what event they just
performed, and therefore what they can or cannot do in the
same and following timesteps.
Proliferation, elongation and migration of endothelial
cells in a growing sprout are represented through the
movement of nodes (Figure 2). Throughout the steps in
angiogenesis, we focus on three activated nodes repre-
senting the tip cell and the adjacent stalk cell segment in
every sprout. These nodes are introduced as follows
(Figure S1):
(1) Node A, Leading node of the tip cell (red in Figures 2
and S1)
(2) Node B, Shared node of the tip and adjacent stalk
cells (yellow in Figures 2 and S1).
This is the back node of the tip cell and leading node of
the adjacent stalk cell segment.
(3) Node C, Back node of the adjacent stalk cell segment
(blue in Figures 2 and S1)
We describe the sequence of events that define the
computational processes representing sprout growth, in
the context of these nodes. The following paragraphs
discuss the processes modeled: cell activation; cell
s e n s i n go fg r o w t hf a c t o r s ;c e l lm i g r a t i o n ,p r o l i f e r a t i o n
and elongation; cell branching and the process of a
sprout joining an adjacent vessel or another sprout. In
Appendix 2, we define in more detail events from to,t h e
time at the onset of angiogenesis, to tn, a time at any
interval following the appearance of a sprout. In Figure 3,
we provide a flow chart of the processes to illustrate their
connectivity.
Cell Activation
In experiments of angiogenic sprouting, a single cell is
initially shown to branch out in a spindle-shaped
fashion from an existing vessel [41-43]. This tapered
sprout tip is a highly polarized cell, which expresses
genes differently than adjacent stalk cells, including
higher levels of VEGFR2 and PDGFb [1]. The tip cell also
proliferates with a much lower probability than stalk
cells [1, 13] (Table 4).
Cells in an existing blood vessel can be activated by a
threshold increase in VEGF protein levels [44]. One cell
becomes the tip cell, and a cell adjacent to this tip cell
becomes an activated proliferating stalk cell. By secreting
matrix degradation proteases like matrix metalloprotei-
nases (MMPs), a tip cell proteolyses its surrounding
extracellular matrix and releases matrix-stored growth
factors [45, 46]. We restrict our initial model to
considering the effect of chemical factors on tip and
stalk cell response. MMP secretion and matrix degrada-
tion are assumed constant. Haptotaxis and the effect of
the matrix are represented by adjusting the second term
in the cell migration rates, a term that depends on
collagen content (Table 3; see Equation S3). The growing
s p r o u t ,l e a db yt h et i pc e l l ,m o v e sa l o n gag r o w t hf a c t o r
concentration gradient, towards the source of higher
VEGF. Active stalk cells may change in shape and
position, and proliferate, so long as the stalk cell
adjacent to the tip cell remains connected to the tip
cell throughout.
The computational representation of activation is as
follows. An endothelial cell on an existing capillary can
be activated in the model when one of its segments is
activated. At to,t h eo n s e to fa n g i o g e n e s i s ,t h e r ei sa
search routine over all the cell segments in the model of
the existing capillary network. A cell segment is activated
when both its nodes sense a level of VEGF above a
specified concentration threshold, VEGF_activate (Table
S1, see Additional file 1). These nodes are labeled
activated nodes. With a certain probability limited by the
number of tip cells per capillary, a probability defined by
the variables tipNumber and tipNumberFrac (Table S1,
see Additional file 1), a sprout may originate from one of
these activated nodes. Once a sprout forms from a node,
n o d e sa d j a c e n tt oi to nt h ee x i s t i n gc a p i l l a r yb e c o m e
inactivated.
Cell Movement Following Activation
Cellular Sensing of Local Growth Factor Gradients
The local maximum VEGF gradient ∇[VEGF]max for the
leading tip cell node is determined by a local search
surrounding the node. For a node at position X(i,j,k), the
maximum change in growth factor concentration
Table 4: Boolean variables determining cell rules
Variable Definition Value
(Default in Bold)
ProliferationTipOn Do tip cells proliferate? True or False
ProliferationStalkOn Do stalk cells proliferate? True or False
MigrationTipOn Do tip cells migrate? True or False
ElongationOn Can cells elongate? True or False
Dll4 Is Dll4 at control levels
or is there Dll4
haploinsufficiency?
0( c o n t r o l )or
1 (haploinsufficiency)
BMC Systems Biology 2009, 3:13 http://www.biomedcentral.com/1752-0509/3/13
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Illustrations of cell movement represented by rules in the model. For clarity, movement is shown in two-dimensions.
The tip cell is represented by a red node and segment; the node shared between the tip and stalk cells is yellow; and the blue
node and segment is the adjacent stalk cell segment. Black segments and nodes represent quiescent vessels. Arrows represent
direction of movement for nodes. (A) Schematic of a capillary with an activated tip cell. (B) Movement when there is no
growth factor gradient. (C) Movement and the resulting cell segment positions when there is a VEGF gradient, and the effects
of allowed stalk cell elongation. (D) Results when there is only elongation of the stalk cell occurring, and no additional
migration of the tip cell. (E) Results when there is proliferation of the stalk cells.
BMC Systems Biology 2009, 3:13 http://www.biomedcentral.com/1752-0509/3/13
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can be defined mathematically:
ΔΔ CC
ii t o  i
jj t o  j
kk t o  k
oi max ’
’
’
,’ max ⋅= ⋅
=− +
=− +
=− +
hh
11
11
11
i io j jo k k CC ’, ’ ’, ’ ’ +⋅ + ⋅ ⎢ ⎣ ⎥ ⎦ ΔΔ hh
(1)
hi is the weighting vector for the +i direction. This weighing
vectorcouldbedefinedasafunctionofthelocalmatrix,e.g.,
as a function of collagen fiber orientation. For this model,
the matrix is uniform and the weighing vector's magnitude
isuniforminalldirectionsandequalto1.Theprobabilityof
thecellmovingintoapotentialnewpositionisafunctionof
ΔC, the change in concentration of growth factor between
the current position of a cell's leading node (position voxel
o), and the highest concentration of growth factor in a
nearby voxel (position voxel q, defined by the <i',j',k'> set
associated with ΔCmax), divided by the change in distance
between voxel o and voxel q. The larger the positive
concentration gradient, the more likely that the cell's node
moves towards voxel q. Following this local search routine,
the location of the voxel q is where the maximum
concentration change per distance was found.
Figure 3
Flowchart representing the main rules followed by tip and stalk cells throughout a run of the model.T h er u l e s
are interconnected, as illustrated by the arrows.
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The leading node of a sprout moves in the direction of
ΔCmax·h, i.e., d(i,j,k) is a function of ∇[VEGF]max
surrounding the leading node of a tip cell. The local
direction for cell movement is recalculated for activated
tip cell nodes at each timestep. In the discrete 3D grid
used in this version of the model, the directional vector
f o rm o v e m e n to fa na c t i v et i pc e l li sd e f i n e db yc h a n g e s
in the position of its leading node, as follows:
di =
−
−+ −+ −
Xoi Xnew i
Xoi Xnew i Xoj Xnew j Xok Xnew k
,,
( ,, )(,, )(,, ) 22 2
+ +
−
−+ −+ −
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(2)
Where the designation "new" represents the new X(i,j,k)
position determined by the highest local VEGF gradient,
and "o" represents the current one. The directional vector
is a unit vector, and the local search for maximum
concentration gradient is restricted to adjacent voxels.
When there is only one direction for the highest VEGF
gradient surrounding a voxel, then Xnew corresponds to
position voxel q, and d(i,j,k) points in the direction of a
single ΔCmax·h (Equation 2).
Stochasticity is introduced where the highest gradients
are the same in two or more voxels surrounding the
sensing cell node, that is, ΔCmax·h and q have more than
one voxel associated with them. In this case, d(i, j, k) is
chosen randomly (with equal probability) between the
available locations corresponding to the highest gradi-
ent. If all the local concentrations surrounding a cell
node are equal in VEGF concentration, the next position
is chosen with a bias towards persistence, as described
below. If the activated cell is in the position of highest
local VEGF concentration, it will continue to move or
grow, in a direction chosen from all available locations,
also with a persistence bias. The cell searches its local
environment and moves based on this weighted set or
probabilities, i.e., with a weighted random walk.
Persistence
To account for experimentally observed cellular persis-
tence, the probability of moving in specified directions is
weighted. Numerous factors could contribute to the
underlying biology of observed in vivo persistence,
including matrix stiffness, growth factors, filopodia, or
directional sensing from a yet uncharacterized source. To
analyze the contribution of different factors on biased
cell movement, we tested three methods of representing
persistence in the model. The first representation of
persistence was called intrinsic persistence – am e a s u r eo f
the probability that a cell follows along the same path
without deviating direction, independent of growth
factors. This was implemented computationally by a
rule where a tip cell's leading node remembers its
previous location, and a vector is calculated between its
previous location and current one. Then the probability
of the node moving in the next step along that same
vector direction is weighted more heavily; the value of
this probability is defined by the variables dirBias and
denomBias (Table S1, see Additional file 1). While this is
referred to as intrinsic persistence, it is also a means to
implicitly represent the process when the leading part of
a tip cell alters the local extracellular matrix as it moves
(in turn, the extracellular matrix may alter cell integrin
binding, signaling and adhesions properties [47, 48])
and paves a favorable path for any following cell
segments [47, 49, 50]. A second way of representing
persistence was to bias directional movement of cell
nodes in favor of a particular location in the entire
gridspace. For this representation, movement towards
one corner of the grid was weighted more heavily than
other directions, and not as a function of VEGF.
However, beyond offering a chemotaxic stimulus,
growth factors such as VEGF could affect the ability of
a cell to follow a given direction [51]. A third
representation was weighing directional movement as a
function of local [VEGF]. In this implementation, the
dirBias variable became a function of [VEGF]. Finally,
purely random movement of the tip cell's leading node
was compared to the effects of persistence, in the case
where local VEGF concentrations surrounding a node are
equal.
Proliferation, Migration and Elongation
The dynamics of proliferation, migration, and elonga-
tion in the model represent a novel hypothesis as to how
sprout formation is governed by individual cells and cell
segment behavior. The result is a push-pull system
between tip and stalk cells. As the tip cell migrates out of
the existing capillary, it may pull along the stalk cells.
This pulling causes the adjacent stalk cell segment to
elongate. Diverse stimuli affect elongation of cells during
angiogenesis, including growth factors, mechanical
stretch and adjacent cells [22, 52, 53]. We first restrict
elongation to result only from a tip cell pulling. Once a
tip cell stretches the adjacent stalk cell segment, stalk cell
proliferation is stimulated. Stalk cell proliferation in turn
pushes the tip cell forward, resulting in tip cell
migration. The process then repeats: the tip cell
proliferates and migrates towards higher growth factor
levels, pulling along the adjacent stalk cell segment,
which elongates; then the stalk cells proliferate and push
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(page number not for citation purposes)the tip cell forward (for a cartoon representation, see see
Additional file 2). Note that the tip cell can also
proliferate, with a low probability [13].
In the current model, only the stalk cell segment adjacent
to the tip cell elongates, while all the stalk cell segments
and the tip cell are able to proliferate. During elongation,
the volume of a cell remains constant; the cell radius
decreases to compensate for the extended length. The tip
cell and stalk cells have a maximum length and volume,
which provide limits on velocity and elongation. The
following provides the sequential rules that govern the
process of angiogenesis after a tip cell appears. The tip
cell and the adjacent-to-tip stalk cell segment are the
active, moving, growing, and branching segments. The
unactivated stalk cell segments in the capillary sprout, all
those following the adjacent stalk cell, remain in the
position they first establish.
Cell proliferation
Proliferation of the tip cell Ptip is represented in the
model by cell volume changes, with time (Table 3). It is
defined as the same experimental-based equation for tip
cells Ptip and stalk cells Pstalk (Equation 10), however
stalk cell proliferation occurs deterministically whenever
Pstalk is allowed, while the tip cell proliferation occurs
probabilistically as a function of Dll4 (Table 3). Length
changes due to proliferation are directly related to
volume changes. Following tip cell proliferation, the
new radius RP and length ℓ of the tip cell are defined by:
RP = (cellRadius Fract·Ptip +1 ) · R ( 5 )
A =
+⋅
⋅
()
()
Ptip V
RP
1
2 p
(6)
w h e r eRi st h eo l dr a d i u s ,a n dVi st h eo l dv o l u m eo ft h e
tip cell segment.
Total tip cell movement
The total movement or length displacement of a tip cell,
mtotal, at any given time interval tn-1 to tn, is given by:
m
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where Mtip is migration rate of the tip cell. APstalk
andAPtip are length changes of the tip cell due to stalk
cell proliferation and tip cell proliferation, respectively.
Elongation Estalk and proliferation Pstalk of the stalk cells
occur independently and separately, i.e., they do not
occur in the same timestep. The specific Cases 1 and 2
refer to when the adjacent stalk cell segment elongates,
but the stalk cells do not proliferate (Case 1) and when
stalk cells proliferate, but the adjacent stalk cell does not
elongate (Case 2). Rules for cell movement in these two
cases are described in detail in Appendix 2 (see
Additional file 1).
Branching
Branching occurs at a certain probability after the onset
of angiogenesis, and a delay defined by the variable
timeBranching. Currently branching occurs with a
specified probability for every activated cell during
each timestep of the model, if a cell's node senses a
specified threshold of local VEGF concentrations (Table
S1, see Additional file 1). The minimum branch length is
initially set, and the initial angle formed between
branching cell segments is also defined, for the current
model (Table 2). To visualize the branch (and give a
physical dimension to its growth over the 2 hour
timestep), we set a minimum branch length that
corresponded to at least one grid point away, where
growth was allowed in two directions, with a grid size of
1 μm. As an alternative in future models, varying this
length, or making the initial branch length dependent on
proliferation and migration rates, could be possible.
Eventually, the model will include the effect of mechan-
ical forces on cell shape and size; in this case (in
combination with any new experimental evidence), we
would be able to better justify a range of minimum/
initial branching lengths. The branching angle can be
randomly selected to be equal, less or greater than this
maximum default value, for specific conditions. The
presence of Dll4 affects the rate of branching both at the
tip and stalk cells; and the effect of Dll4 haploinsuffi-
ciency on the branching is represented in the model
parameters (Table S1, see Additional file 1). Branching in
the model can occur at a stalk or a tip cell node. For a
detailed description of how branching is implemented,
see Appendix 2 in Additional file 1.
Joining Another Sprout or Vessel
Anastomoses, or the connection of a growing sprout to
another vessel occurs when the leading node of the tip
cell touches an adjacent vessel or another tip cell node,
randomly. This is a first implementation, and subse-
quently activation of the adjacent vessel may be a
requirement for joining of the tip cell. In this initial
model, anastomoses occur infrequently; there is no
restriction on sprout movement by surrounding tissue
or a bias from interstitial fluid flow.
Effects of Dll4
The presence of Dll4 has an effect on those rules
involving tip cell formation, tip cell proliferation, and
branching probability (Table 3). Experimentally, the
observed tip cell number in Dll4
+/- vasculature is near
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difference was used in the model to allow integer
number of tip cells, when observing only a few
capillaries. Note also that the number of tip cells formed
from an existing capillary versus a new capillary formed
by angiogenesis is expected to differ. More tip cell
formation and branching is hypothesized in the newly
formed vessel.
Model Parameters
Table 2 lists the parameters in the model, with their
relevant references. Table S1 provides initial values of all
variables used in the computer code (see Additional
file 1). Table S2 provides parameter estimates for cell
velocity, as found from in vitro 2D and 3D experiments
(see Additional file 1). Velocity values found from Table
S1 (see Additional file 1) were used in part to determine
migration rules (Table 3, Equation 8; Figure S1, see
Additional file 1). Parameters were obtained for
endothelial cells where possible. Where a non-endothe-
lial cell type is used, this estimate is stated explicitly.
Ranges are given for endothelial cell dimensions in
parentheses, and the default values used for this model
are presented (Table 2). The value ranges include sizes
for mammalian cells, in different tissues. The current
model estimates cell and vessel sizes for three-dimen-
sional in vitro conditions, using human umbilical vein
endothelial cells. When the model is applied to a specific
species and tissue, during certain vascular conditions, the
dimensions will be specified for this environment alone.
Platform
The model was programmed in Java, using Sun's Java3D
and MASON (George Mason University, Fairfax, VA,
available online: http://cs.gmu.edu/~eclab/projects/
mason/) libraries. The JAVA IDE used was Borland
JBuilder. Output of the Java code (three-dimensional
position of the cell segments and capillary structures,
and labeling for cell shape and activation status at each
timestep) was written into TecPlot (TecPlot, Inc, Belle-
vue, WA); additional results were written to text files. A
description of the computational architecture in pro-
vided in Appendix 4 (see Additional file 1). For graphical
rendering, the output was read into a user-written POV-
Ray program (POV-Ray is available online: http://www.
povray.org/). A POV-Ray movie was then produced from
a series of these programs.
Sensitivity Analysis
Sensitivity analysis was performed for key parameters.
Cell displacement rates, [VEGF], migration rates, random
weighting, branching probability and timesteps were
adjusted over a wide range of values, while other factors
were held constant. Sample graphs from the sensitivity
analysis are provided in figures, where details of the
parameters are relevant to the results and discussion. An
exhaustive systematic sensitivity analysis can be per-
formed when the model is restricted to a specific tissue
type.
Timestep
The timestep currently is defined as a constant. As
experimental details of events become available, it could
be made variable. There is no inherent limit on the
number of timesteps.
Results
The model results show cellular activation, proliferation,
and movement during the initial steps in angiogenesis.
Four main applications of the model were explored: in
silico knockout experiments, characterization of persis-
tence effects on vessel formation, differentiation of tip
cell and stalk cell branching, and the effect of Dll4
haploinsufficiency on sprouting.
First, to give a basis of how the model's representation of
cell activation and chemotaxis correlates with experi-
ments that can serve as validation of the model,
cumulative sprout length was compared with and
without VEGF at different concentrations. In developing
the model, rules for determining the experimental
relationship between VEGF concentration and cell
migration [54-57] and cell proliferation [44, 52, 57-59]
were estimated from experiments on endothelial cells
(Table 3, and Table S2, see Additional file 1). Cell
proliferation experiments were 2D in vitro cell culture
assays, and cell migration experiments used VEGF as a
stimulus for movement of cells in a Boyden chamber
assay. In vitro experiments provide an estimate in the
computational model for the maximum in vivo changes
in response to an activated cell sensing a specified local
concentration of VEGF. The effect of VEGF concentration
on sprout formation was then predicted by the simula-
tion in three dimensions (Figures 4A and 4B). The model
output was qualitatively compared to independent data
(data not used in developing the model rules) from
experiments on sprout length changes as a function of
VEGF in three-dimensional HUVEC spheroid experi-
ments (Figure 4C) [60-64]. Without VEGF or with local
VEGF levels less than 0.6 ng/ml, the cells in the model
do not become activated, and there are no cumulative
sprout length changes.
Migration, Proliferation and Elongation
Once the premise of cell activation by a threshold VEGF
and migration in response to a VEGF gradient was
established, varied combinations of the migration and
BMC Systems Biology 2009, 3:13 http://www.biomedcentral.com/1752-0509/3/13
Page 12 of 24
(page number not for citation purposes)proliferation rules were explored. One highlight of the
described modeling approach is that methods were
designed with modularity. The effects of allowing or
prohibiting processes that would not be feasible to
manipulate independently in vivo, can be predicted for
specific cell types. Figure 5 shows the effects of altering
migration and proliferation differentially in tip and stalk
cells, for the Experiments 1–6 detailed in Table 5. There
are 32 possible combinations of experiments from
manipulating the five Boolean values for initial vari-
ables. Boolean values indicate whether or not five
processes are allowed (proliferation of the tip cell,
Figure 4
Relative effect of [VEGF] on total vessel growth over time.( A )a n d( B )E f f e c t so f[ V E G F ]a l o n eo nt o t a lv e s s e ll e n g t h .
Initial number of capillaries was three, and the number of initial sprouts varied from two to six, with branching allowed.
Simulation sample size was five values for each concentration at a given time. Growth for this simulation was unrestricted in
i- and j-planes, and the dimension of the k-axis was 400 μm. [VEGF] gradients and initial cell activation level ([VEGF] = 0.6 ng/ml)
were held constant for all compared [VEGF] concentrations. (C) and (D) Comparison of sprout length changes as a function of
VEGF (ng/ml) to experiments using human endothelial cell spheroids on 3D collagen gel. (C) shows fold increase compared to
the control in each experiment, while (D) shows absolute changes in vessel length fo rt h es a m ee x p e r i m e n t s .V a l u e sa r ef o r
growth from a single spheroid. Experiments in references [60-64] were for a mean of 10 spheroids, embedded in a matrix of
collagen from rat-tails. Experiments in [60-62, 64] used HUVEC alone in the spheroids, while reference [63] used a coculture
of HUVEC and human umbilical artery smooth muscle cells. All experiments used 50 ng/ml VEGF165 alone as the stimuli,
except [61], where 25 ng/ml VEGF165 and 25 ng/ml bFGF were added. Experimental data are shown by the purple bar [60],
yellow bar [63], blue bar [61], orange bar [64] and red bar [62].
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elongation of tip and stalk cells, and presence of Dll4
ligand). Initial total capillary length is 127 μm, at 0 hrs,
for all model runs. Experiment 5, where no process is
permitted, indicates near base line values; in this case,
the only growth or cellular addition is the initial
formation of tip cells. Experiment 6, on the other
hand, stands in for a positive control – all processes
are on, and maximum growth and proliferation of both
tip and stalk cells are expected. Figure 5C shows how
branching is related to elongation and proliferation.
Without one or the other, there is no branching
Table 5: In silico experiments shown in Figure 4
ProliferationTipOn ProliferationStalkOn MigrationTipOn ElongationOn D114
Experiment 1 false true true true 1
Experiment 2 true true true false 1
Experiment 3 true false true true 1
Experiment 4 false false true true 1
Experiment 5 false false false false 1
Experiment 6 true true true true 1
Figure 5
Results from the in silico experiments. Total vessel length from 2–72 hrs (A), a snapshot of vessel length 24 hrs after the
onset of sprouting angiogenesis (B), and relative branching points over time (C) for the different in silico experimental
configurations shown in Table 6. Dll4 = 1 corresponds to wild type, control conditions for this ligand.
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whenonlytipcellproliferationisturnedoff(Experiment1).
Persistence
Representations of persistence were compared graphi-
cally (Figure 6). Figure 6 shows the calculations for
persistence weighting and the effect on total vessel length
over time. When VEGF levels are not uniform, using a
search routine for a local gradient (VEGF concentrations
directly adjacent to the cell's leading edge) combined
with intrinsic cell persistence, produces some random
movement of cells (Figures 6A and 6C). When the tip
cell's intrinsic persistence is replaced by a biased weight
towards a particular grid location, the results are shown
(Figure 6B) and compared to length changes in time
where there is 20% intrinsic persistence (Figure 6D).
With uniform VEGF levels in the grid, entirely random
tip cell motion limits the planar-XY growth perpendi-
cular from the initial vessels (Figure 6E), while also
limiting the total length of capillary growth (Figure 6F).
Without a biased directional preference by cells, the
model predicts a tortuous vascular network, regardless of
t h en u m b e ro rd e g r e eo fa c t i v a t e dc e l l s .O t h e rf a c t o r sn o t
yet explicitly modeled that could affect persistence
include collagen fiber alignment, and the influence of
contact guidance [65].
Branching
The effect of branching on total vessel length is shown in
Figure 7. At the onset of angiogenesis, there is little
branching; the model predicts it is not until 48 hrs in the
default microenvironment, that branching has a signifi-
cant effect on the total vessel length changes (Figure 7A).
Branching predicted by the model correlates to results
from available in vitro and in vivo experiments. In
HUVECs cultured in 24-well plates with Matrigel (total
volume 1.9 ml, 190 mm
2 culture area, dimensions found
from Corning Cell Culture) at 10,000 cells/well, the
number of branch points at 24 hrs ranged from ~5 for
cells without growth factor to ~80 for cells cultured with
100 ng/ml soluble Dll4 [66]. Scaling these in vitro
findings to the dimensions of 400 μm×1 0 0μm×1 0 0
μm (dimensions spanned by three initial capillaries and
maximum growth), an estimate would be 0–2b r a n c h e s
in 24 hrs, which is what the model predicts at 10%
branching for timesteps of 2 or 3 hrs (Figure 7D).
Dll4
Figure 8, and Movies 2, 3 and 4 (see Additional files 3, 4
and 5), show the effect of hypothetical haploinsuffi-
ciency of Dll4 during sprouting. As Dll4's activity is
ingrained in the rules, this is to demonstrate the model's
capability to be used as a means to represent phenotypes
of in silico knockouts and show the effect of global
changes from rules at the single cell and single time-step
level. In Figure 8A, the total relative length change in
control conditions is compared to conditions where Dll4
is haploinsufficient. The number of sprout tips as a
function of VEGF levels in both conditions are compared
in Figure 8B.
Discussion
This model introduces the steps of cellular sprouting
during angiogenesis in a manner that is biologically
relevant and consistent with experimental observations.
Many previous computational models of angiogenesis
have been based on equations or rules governing
generalized growth factors, without specifying the
molecular nature and properties [16, 24]. Where VEGF
and FGF have been considered specifically, a two-
dimensional model provided results with good qualita-
tive agreement with experiments [20]. Models have been
deterministic [24] and stochastic, and included differ-
ential equations [24], as well as discrete models [21],
such as cellular automaton [20]. The agent-based model
introduced here offers a three-dimensional, detailed look
at the steps in cellular activation, proliferation and
movement during angiogenic sprouting. It shows how
chemotaxis alone, from a VEGF gradient, affects the
velocity and growth of vessel sprouts. The model predicts
the degree to which VEGF concentrations beyond an
activation threshold influence total vessel length changes
(Figure 4), ranks the key individual factors in migration
and proliferation by differentiating tip and stalk cell
events (Figure 5), explores three potential mechanisms
altering cellular persistence (Figure 6), offers one
perspective on how branching and vessel length changes
could be correlated (Figure 7) and predicts global
angiogenic changes to knockout conditions both knock-
outs at the level of Dll4 receptor binding (Figure 8) and
cell-specific processes (Figure 5).
VEGF Concentrations vs. VEGF Gradients
VEGF is one of the main growth factors involved in
angiogenesis. Experimental studies have predicted that
the absolute VEGF concentration and the VEGF gradient
play separate roles in new blood vessel formation, in a
microenvironment-dependent way. The current model
represents a situation that might be found for capillary
growth in a 3D in vitro setting with human endothelial
cells sprouting from an existing vasculature. Perhaps
surprisingly, the model predicts little effect of absolute
[VEGF] concentration on overall vessel growth in three-
dimensions within the range of 1–25 ng/ml (Figures 4A
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Persistence comparisons. (A) through (D) use the default VEGF gradient (Table 3). Visual examples of how directional
persistence affects capillary sprout morphology. (A) and (B) show two snapshots of random tip cell movement (A) and 20%
intrinsic persistence weighting (B) in tip cell movement, at 48 hours. (C) Total vessel length from 2–72 hrs for the model,
comparing 20% to 40% intrinsic persistenc e .( D )T o t a lv e s s e ll e n g t hc h a n g ef r o m2 –72 hrs comparing intrinsic persistence of
20% with global persistence at 20% and 40% directional weighting. For (C) and (D), VEGF concentration is set as a uniform 0.6
ng/ml at each voxel point in the grid, i.e., there is uniform concentration and no gradient. (E) Maximum XY-plane distance
reached beyond initial capillary structures for intrinsic persistence weighting of 20% compared to a random weight. (F) Total
vessel length from 2–72 hrs for 20% intrinsic persistence weighting vs. random movement.
BMC Systems Biology 2009, 3:13 http://www.biomedcentral.com/1752-0509/3/13
Page 16 of 24
(page number not for citation purposes)Figure 7
Analysis of the model's representation of branching for in vitro conditions in three dimensions.( A )V e s s e ll e n g t h
over time for stalk cell branching at a probability of 10% and 30%. (B) Corresponding number of branching points for (A).
Insets show large scaled values for 2–24 hrs.
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Effect of haploinsufficiency of Dll4 on blood vessel sprouting compared to control conditions.( A )C o m b i n e d
effect of [VEGF] and Dll4 haploinsufficiency (Dll4
+/-) on total vessel growth after 24 hours. (B) Number of sprout tips as a
function of [VEGF] and Dll4 haploinsufficiency after 24 hours. For (B), [VEGF] represents both the initial [VEGF], and the
[VEGF] used in migration and proliferation rates. Gridspace volume is 1.28 × 10
6 μm
3; initial tips were counted after two
hours of stimuli. (C) and (D) Visual snapshots of the model output for control conditions (C) and Dll4
+/- (D) after 24, 40 and
200 hrs, with a mean local VEGF concentration above the activation threshold of 0.5 ng/ml. The 24 and 40 hrs runs are in 3D,
while the 200 hrs run is shown in 2D.
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(page number not for citation purposes)and 4B). At 50 ng/ml VEGF, the average increase in vessel
length looks noticeably higher compared to ≤ 25 ng/ml
VEGF (Figure 4A, orange and yellow area). However, the
degree of variation in vessel length changes is very high
at this concentration, and in some instances, vessel
length change could be similar to those at lower
concentrations (Figure 4B). From visual representations,
this phenomenon reflects the possibility of two condi-
tions: one, the initial vessels sprout extensively outward,
without physical limitations, and two, the sprouts grow
randomly and then back on themselves, limiting total
length changes. Thus, from the model, it would be
predicted, that where there is no VEGF gradient and cells
are activated, total vessel length increases significantly
from 24–72 hrs (8× or more), though largely indepen-
dent of the concentration of VEGF beyond 1 ng/ml; this
is in good qualitative agreement with the trend lines for
VEGF dependence from experiments using a bovine
aortic endothelial cell radial array assay, which showed
saturation in vessel length changes with increasing
[VEGF] [67]. Furthermore, the model predicts that
increasing overall uniform VEGF concentration increases
the variability in the length changes. In qualitatively
comparing the model predictions to experimental
measurements of sprout increase as a function of VEGF
and time in HUVEC spheroid models seeded in a
collagen gel, two things are of note. One, the variability
in results from one experiment to another is high (Figure
4C), while two, the sprout length changes are generally
less than that predicted by the model at 48 and 72 hrs
(Figure 4D). This latter observation may reflect that the
current model has no boundary restrictions. In vivo, the
sprouting capillaries would be restricted by tissue and
other vasculature, and in vitro, the extracellular matrix
could affect growth differently than modeled, as could
the limited viability of the cells in culture. In the current
simulation, there is no mechanical limitation on their
growth and only several initial capillaries present in the
model; moreover, cell apoptosis and vessel pruning has
yet to be considered. In further renditions of the model,
it will be important to test the effect of larger capillary
networks; the presence of other cells and tissues; and the
effect of apoptosis and vessel pruning.
While independent rules for migration and proliferation
are a function of absolute VEGF concentration, the
driving force for angiogenesis predicted by the model is
VEGF gradient (Figure 4B). The structure of the
vasculature in the simulation changes over time, and
this is caused by VEGF gradients stimulating a directed
growth with the described push-pull phenomenon
associated with tip and stalk cells. The VEGF gradient
provides a chemical cue that promotes the motion of the
tip cell. Increases in VEGF concentration alone do not
have this effect, but rather increases speed and random
motility of cells, in the model; this has also been
supported experimentally [51, 68]. Once the leading
node of the tip cell moves, the adjacent stalk cell
elongates or grows to maintain contact and vessel
integrity.
Beyond what has been modeled and discussed so far,
there are a number of other factors that influence VEGF
gradients and a cell's response to them. Endothelial cells
themselves may secrete VEGF as they form a sprout.
O u t s i d et h ep r i m a r ys o u r c eo fV E G Fs t i m u l i ,c e l l ss u c ha s
pericytes, endothelial cell precursors and smooth muscle
cells may influence VEGF levels by secretion or physical
position. Extracellular matrix heterogeneity and the
presence of different VEGF receptor isoforms and
heparin binding groups on cells would also alter the
response to VEGF gradients.
Proliferation
We define the probability of proliferation of tip and stalk
cells to be different, but the rate of proliferation, once
initiated, to be the same. Another way of representing
observed differences in cell number between tip and
stalk cells, would be to change the rate of proliferation,
and keep the probability uniform. The rationale for
using the first was that a tip cell has in the past been
considered as nonproliferating, leading to a hypothesis
that the ability to proliferate increases in different
conditions, and that there are subpopulations of
proliferating and nonproliferating tip cells.
Knockout Experiments: Elongation, Proliferation and
Migration
In the model, it is predicted that cell elongation has a
significant effect on total vessel length (Figure 5B, Experi-
ments 2 and 5, and Table 5). This is because elongation is
the stimulus for cell proliferation and migration; without it,
the cell may migrate to an extent, but will not proliferate
untilstimulated.TheeventknockoutexperimentsofTable5
and Figure 5 also reflect the extent to which stalk cell
proliferation dominates tip cell proliferation. The total
vessel changes in Experiments 3 and 4 are nearly identical,
where the difference between them is only that Experiment
4 has both tip and stalk cell proliferation restricted whereas
Experiment 3 has just stalk cell proliferation restricted.
Furthermore, Experiment 1 has a similar pattern of growth
to Experiment 6, where again the only difference is the
ability of the tip cell to proliferate in Experiment 6.
Persistence
Without a heavily biased directional preference by cells,
the model predicts a very tortuous vascular network
(Figure 6). These results were based solely on a search
routine for a local gradient (VEGF concentrations
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with intrinsic cell persistence. This implies that a highly
random movement of cells would be present in
angiogenesis, even with a local chemotaxic signal, if
the extracellular matrix had no effect on cell migration.
Alternately, this suggests that the sensing of growth
factors like [VEGF] goes beyond local changes, and
requires sensing gradients at longer distances than a few
microns. If a cell is sensitive to local changes in [VEGF]
on the order of microns, the latter hypothesis gives
credence to a balance between gradient sensing at a
longer distance scale (e.g., by filopodia) and local
sensing at the cell surface. It has been shown that retinal
endothelial cell filopodia can extend beyond 100 μm,
and they are capable of sensing and responding to VEGF
via VEGFR2 [1]. Another study indicated endothelial
cells can sense directionality in 3D collagen gel for
distances of 600–800 μm [62]. These experimental
observations support modeling persistence as a function
of growth factor concentration as well as a function of
the intrinsic probability of following a continuous path
in a given direction.
Delta-like ligand 4 Signaling
Delta-like ligand 4 (Dll4) is a transmembrane ligand for
Notch receptors, and it is critical to vascular develop-
ment. So important is Dll4, that like VEGF, haploinsuf-
ficiency of the Dll4 gene is embryonically lethal in many
mice strains, as a result of extensive vascular defects
[7-9]. Dll4 is primarily expressed in endothelial cells,
and correlated to the local concentration of VEGF. The
model predicts the effects of a Dll4
+/- on the phenotype
of new vessel growth (Figure 8). In the Dll4
+/- knockout,
the vessels show greater total vessel length compared to
those in simulated controls (Figure 8; Movies S1 and S2,
for control and Dll4
+/-, respectively). This increase results
from a combination of an increase in the total number of
sprout tips (Figure 8B), greater tip cell proliferation rates,
and greater degree of branching (Movie S3, see Addi-
tional file 4) in Dll4
+/- vasculature. The absolute
magnitude of Dll4 concentration could not be predicted
in the current model, based on existing rules (Table 3);
these rules can be amended as experimental data
becomes available.
It is worthwhile to mention limitations of the current
model in resolving existing experimental observations
on Dll4 effects during angiogenic sprouting. Studies have
indicated an increase in vessel diameter in Notch-
inhibited cell cultures [12], while others have shown in
Dll4
+/- retina microvasculature, vessel size is similar to
wild type, and the increase in vessel density is attributed
predominantly to increased sprout numbers [69]. The
model represents the latter as a first approximation. It
may be that both situations occur, depending on the
local microenvironment, existing vasculature, and degree
of Dll4
+/- and Notch expression. Furthermore, here we
simplify the system by rules that define the effects of
Dll4 haploinsufficiency. In the future, Dll4 expression
being induced by VEGF or Dll4 downregulating the
expression of VEGFR2 merit consideration [10, 70].
Heterogeneity and location of Dll4 and Notch expres-
sion among the endothelial cell population may play a
significant role in formation of sprouts, and VEGF signal
transduction. For example, transiently Notch may be
overexpressed by stalk cells, inhibiting the production of
new sprouts [71]. Currently, the model limits the
number of tip cells present under different conditions
(control and Dll4
+/-), an implicit representation of the
signaling that occurs to limit activated cells adjacent to a
sprout from also becoming a sprout and disintegrating
the integrity of the existing vasculature.
Beyond restrictions in how the model represents Dll4
+/-,
other limitations of the current model warrant discus-
sion. In this model, numerous known biological entities
and processes are not considered: hypoxic-induction of
HIF1; HIF1-dependent regulation of VEGF; isoforms of
HIF and HIF's hydroxylation proteins; VEGF isoforms; a
non-uniform extracellular matrix; and matrix-cell inter-
actions, beyond a general representation of how matrix
composition contributes to migration (Table 3, Equation
9); VEGF release from the extracellular matrix by
endothelial cell-released MMPs; the dynamics of base-
ment membrane deposition around the stalk cell; the
effects of parenchymal and stromal cells; and vessel
retraction. Experimentally, chemotaxis can generate
neovascularization [72], and for the current model, we
neglected mechanical factors, including fluid shear stress
and explicit changes in matrix stiffness. In future studies,
it would be interesting to examine in detail, the
contribution of mechanical cues, matrix density and
haptotaxis on cell response in angiogenic sprouting, as
well as all of the above-mentioned factors that influence
angiogenesis.
Other considerations include that capillary lumen and
vessel diameter may change in response to angiogenic
stimuli, as has been shown in hepatocellular and
pancreatic tumors [73]. Assuming that VEGF concentra-
tion is constant is an initial simplification; in reality,
during angiogenesis, endothelial cells uptake and may
produce VEGF.
T h e r ea l s or e m a i n saq u e s t i o na st oh o wa n dw h e n
adjacent capillaries connect. In the current model,
sprouts or vessels connect when in contact. Further
studies should elucidate how the sprout tip of one
activates the other, and the degree to which the
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collagen fibril alignment [62]. Tip cell filopodia, whose
length could be upwards of 100 μmi nr e t i n a l
endothelial cells [1], may sense adjacent vessels and
contribute to the formation of capillary anastomoses, as
well. In vitro, endothelial cells have been shown to sense
collagen gel alignment over 600–800 μma w a y[ 6 2 ] .
Additionally, average capillary length in experiments of
angiogenic sprouting is reported with wide variability
(on the order of ten microns to many hundreds of
microns), and depends highly on the microenvironment
[74] and type of endothelial cell.
Another possibility is that Notch-Delta signaling dictates
the attachment of sprouting vessels to adjacent vessels.
Currently the model includes attachment of one vessel
to an existing one, or two sprouts joining, randomly,
when they physically touch. It is possible only two
activated cells can join. Along with testing out different
means of vessel fusion, future model versions would
explore the effects of apical-basal cell polarity, the
necessary flipping of polarity during sprout formation
and alterations in vacuole formation (for a review and
schematic, see [71]).
Diverse approaches to computationally representing
angiogenesis can yield similar results, particularly in
relation to capillary network formation. Examples are an
energy-minimizing model [21], a mechanical stimuli-
based model, a two-dimensional cellular level model
[20] and a generic systems model [75]. The question
then arises, how are these models related to one another?
The methodology presented here allows different influ-
ences on cell growth, proliferation and other cellular
processed to be considered explicitly and in accordance
with experimental data.
One goal of this cell-based model is to build a general
framework that would allow it to be combined with
models of intracellular molecular interactions, and
membrane receptor-ligand binding and signaling [19,
39, 76-81]. Molecular models carry the advantage that
individual compounds and reactions are often the
building blocks for therapeutic development. The cell-
level model, in turn, provides other benefits – modeling
cell behavior at a level where not all molecular details are
known, and when an event (e.g., proliferation, migration
as a function of growth factor) or sequence of events
governs capillary growth. We further the field of
angiogenesis systems modeling by approaching scientific
questions from the cellular and tissue level. As the focus
of the current study was on the effects of cellular
proliferation, migration and elongation on vessel growth –
molecular details were not required to answer questions
of interest. When tied to the molecular level models, a
resulting multiscale simulation would be able to show
how molecular interactions influence cellular behavior,
w h i c hi nt u r nd e t e r m i n e st i s s u ep h e n o t y p e s[ 8 2 ,8 3 ] .
Conclusion
In sum, this cell-based in silico model of angiogenesis
shows the relationship between growth factor gradients,
receptor-ligand presence, cell sprouting, cell migration,
cell elongation and cell proliferation in three dimen-
sions. The model shows how representing random
movement, persistence by intrinsic means, or persistence
by a function of VEGF concentrations alters phenotypic
vessel length changes. Furthermore, benefiting from the
modularity of the computer methods, we demonstrated
the effects of migration separate from proliferation on
tip cell and stalk cell movement. Finally, the model
represents findings of how Delta ligand changes influ-
ence capillary phenotype and presents a three-dimen-
sional framework upon which to test and develop
biologically realistic mechanisms underlying blood
vessel growth.
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